![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
I attended an Informed Investors Forum one week ago in San Francisco. A keynote was delivered by Peter Freudenthal of BA Roberston Stephens (Vice President and Sr. Biotechnology Analyst). He indicated that consolidation on both the sell side and the buy side would leave many low-priced biotechs as orphans, that there wouldn't be enough analyst coverage. He likened good news for such companies to a Tree, Falling In a Forest...... nobody would hear it. Let's get loud and defeat such arrogance. You are welcome to convince me to add or drop a company from the portfolio. techstocks.com | ||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2026 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |